TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017

SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis.

Ruben A Mesa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.